Search company, investor...

Poly Pharmaceuticals

Founded Year



Acquired | Acquired

About Poly Pharmaceuticals

POLY Pharmaceuticals is focused on developing and marketing branded, generic, and OTC pharmaceutical products. This remains our focus today. Poly markets a broad range of health care products for conditions such as cough, cold, allergy, sinusitis, pain relief, and urological health. On October 21st, 2021, Poly Pharmaceuticals was acquired by ADDvise. The terms of the transaction were not disclosed.

Headquarters Location

2720 Cullom Blvd.

Owens Cross Roads, Alabama, 35763,

United States

Missing: Poly Pharmaceuticals's Product Demo & Case Studies

Promote your product offering to tech buyers.

Reach 1000s of buyers who use CB Insights to identify vendors, demo products, and make purchasing decisions.

Missing: Poly Pharmaceuticals's Product & Differentiators

Don’t let your products get skipped. Buyers use our vendor rankings to shortlist companies and drive requests for proposals (RFPs).

Latest Poly Pharmaceuticals News

ADDvise receives order worth USD 3.5 million

Jan 20, 2023

ADDvise Group AB Fri, Jan 20, 2023 21:05 CET ADDvise Group AB’s subsidiary Poly Pharmaceuticals Inc has received an order from AxisCare Health Logistics Inc, a company distributing equipment and medical supplies to hospitals, clinics, medical offices and medical equipment suppliers. The order is worth approximately USD 3.5 million. The order consists of delivery of the prescription dietary supplemental Folite, developed and manufactured by Poly Pharmaceuticals. Delivery will take place during Q1 2023. For further information, please contact: Rikard Akhtarzand, CEO Important information: This information is by ADDvise Group AB required to disclose under the EU Market Abuse Regulation. The information was submitted for publication on January 20, 2023, at 21:05 CET. About ADDvise Group ADDvise Group AB (publ) is a leading supplier of equipment to healthcare and research facilities. The group consists of two business areas, Lab and Healthcare. Sales are global. The Group has a clear acquisition strategy with the aim of raising shareholder value and expanding the business – both geographically and product-wise. ADDvise Group’s shares are listed on Nasdaq First North Premier Growth Market and Mangold Fondkommission AB is the Company’s Certified Adviser. Additional information is available at

Poly Pharmaceuticals Frequently Asked Questions (FAQ)

  • When was Poly Pharmaceuticals founded?

    Poly Pharmaceuticals was founded in 1980.

  • Where is Poly Pharmaceuticals's headquarters?

    Poly Pharmaceuticals's headquarters is located at 2720 Cullom Blvd., Owens Cross Roads.

  • What is Poly Pharmaceuticals's latest funding round?

    Poly Pharmaceuticals's latest funding round is Acquired.

  • Who are the investors of Poly Pharmaceuticals?

    Investors of Poly Pharmaceuticals include ADDvise Group.

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.